# ICON plc
> ICON plc is a global provider of outsourced drug development and commercialisation services to pharmaceutical, biotechnology, medical device industries, and government and public health organisations. They offer a comprehensive range of solutions across the clinical trial lifecycle, leveraging human expertise, data, and artificial intelligence to accelerate therapies for a healthier world.
- URL: https://optimly.ai/brand/icon-plc
- Logo: https://logo.clearbit.com/https://www.iconplc.com/
- Slug: icon-plc
- BAI Score: 55/100
- Archetype: Incumbent
- Category: Healthcare Services
- Last Analyzed: August 2, 2026
## Buyer Intent Signals
Problems: Internal Pharmaceutical/Biotech R&D: Companies conducting all clinical trial design, execution, data management, and regulatory affairs solely with their in-house teams, which can be resource-intensiv | Specialized Clinical Consulting Firms: Smaller consulting agencies offering niche expertise in specific areas like regulatory strategy, biostatistics, or market access, but without the full end-to-end | Limited or No External Support: Forgoing external CRO services, which could lead to slower drug development timelines, increased operational risks, higher internal costs, and potential challenges in n
Solutions: ICON plc clinical research organization | drug development services with AI | biotech clinical trials support | market access consulting pharma | cardiac safety solutions clinical | Standalone Clinical Trial Software Vendors: Providers of specific software tools for Electronic Data Capture (EDC), Clinical Trial Management Systems (CTMS), or eTMF, which manage components of a tria